The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial

The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial

Abstract Background The prognostic value and optimal resection outcome related factors of the secondary cytoreduction surgery (SCR) in Platinum-sensitive recurrent ovarian cancer (PSOC) patients were still in doubt. The present retrospective study aims to determine the relationship between the objec...

Full description

Bibliographic Details
Main Authors: Hongyuan Gu, Rui Zhou, Jing Ni, Xia Xu, Xianzhong Cheng, Yan Li, Xiaoxiang Chen
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Journal of Ovarian Research
Subjects:
Epithelial ovarian cancer
Platinum sensitive recurrent ovarian cancer
Secondary cytoreductive surgery
Secondary neo-adjuvant chemotherapy
Time to progression
Platinum free interval
Online Access:http://link.springer.com/article/10.1186/s13048-020-00673-0

Internet

http://link.springer.com/article/10.1186/s13048-020-00673-0

Similar Items